Study reveals mechanisms behind myeloma multicellular sensitivity to EZH2 inhibition
Researchers from Uppsala University show in a new study that inhibition of the EZH2 protein can reduce cancer cell growth in many blood cancer myeloma. The decrease is caused by changes in the meta…
